Lead Product(s): Miconazole
Therapeutic Area: Infections and Infectious Diseases
Highest Development Status: Approved Product Type: Small molecule
Partner/Sponsor/Collaborator: m8 Pharmaceuticals
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Licensing Agreement February 18, 2020
m8 Pharmaceuticals and Vectans Pharma have signed an exclusive licensing agreement whereby m8 will have the rights to register and commercialize Loramyc® (miconazole) for Mexico and Brazil.